FIRST TRUST ADVISORS LP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q4 2022$5,768,142
+1007.1%
78,639
+1046.8%
0.01%
+600.0%
Q3 2022$521,000
-74.7%
6,857
-75.0%
0.00%
-50.0%
Q4 2021$2,061,000
-92.6%
27,455
-88.5%
0.00%
-93.3%
Q3 2021$27,811,000
+51.3%
239,403
+188.9%
0.03%
+50.0%
Q2 2021$18,380,000
-28.6%
82,862
-57.5%
0.02%
-35.5%
Q1 2021$25,745,000
-44.6%
194,776
-27.5%
0.03%
-50.0%
Q4 2020$46,463,000
+1691.2%
268,508
+513.8%
0.06%
+1450.0%
Q2 2020$2,594,000
-41.6%
43,744
-33.7%
0.00%
-60.0%
Q1 2020$4,444,000
-31.0%
65,992
-13.7%
0.01%
-9.1%
Q4 2019$6,444,000
-6.3%
76,464
-16.9%
0.01%
-15.4%
Q3 2019$6,879,000
+12.2%
91,984
-5.1%
0.01%
+8.3%
Q2 2019$6,130,000
+28.5%
96,943
-2.1%
0.01%
+33.3%
Q1 2019$4,769,000
+32.4%
99,013
-7.9%
0.01%0.0%
Q4 2018$3,601,000
-60.8%
107,546
-38.6%
0.01%
-47.1%
Q3 2018$9,181,000
+105.6%
175,208
+22.8%
0.02%
+88.9%
Q2 2018$4,465,000
+79.2%
142,665
+24.8%
0.01%
+50.0%
Q1 2018$2,492,000
-14.4%
114,324
-20.7%
0.01%
-14.3%
Q4 2017$2,912,000144,1550.01%
Other shareholders
NOVOCURE LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Nordwand Advisors, LLC 1,515,000$111,125,24913.86%
Invus Financial Advisors, LLC 350,884$25,737,34113.70%
HARTLINE INVESTMENT CORP/ 304,482$22,333,7555.08%
GREAT POINT PARTNERS LLC 241,000$17,677,3503.46%
Tri Locum Partners LP 72,400$5,311,0002.15%
Taylor Frigon Capital Management LLC 42,061$3,085,1741.75%
HighVista Strategies LLC 28,007$2,054,3131.22%
HAP Trading, LLC 124,500$10,2941.05%
Private Harbour Investment Management & Counsel, LLC 12,285$901,1050.99%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 32,000$2,344,0000.72%
View complete list of NOVOCURE LTD shareholders